Cargando…
BiRd方案治疗复发难治多发性骨髓瘤的回顾性研究
OBJECTIVE: To evaluate efficacy of the BiRd regimen, a combination of clarithromycin, lenalidomide, and dexamethasone, in the treatment of patients with relapsed/refractory multiple myeloma (RRMM). METHODS: Patients with RRMM treated with BiRd between September 11, 2013 and August 1, 2016 at six cen...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364962/ https://www.ncbi.nlm.nih.gov/pubmed/29166734 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.003 |